Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor.

Author: ChhabraShakuntala, TickooChandan

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To compare the efficacy and side-effects of low-dose sublingual misoprostol and i.v. methylergometrine for active management of the third stage of labor. METHODS: The study subjects were three hundred low-risk women with term pregnancy and spontaneous onset of labor. These women received...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1447-0756.2008.00843.x

データ提供:米国国立医学図書館(NLM)

Low-Dose Sublingual Misoprostol Versus Methylergometrine for Postpartum Hemorrhage

This study delves into the realm of obstetrics, specifically focusing on the management of the third stage of labor. The authors compare the efficacy and side effects of two drugs, low-dose sublingual misoprostol and intravenous methylergometrine, in preventing postpartum hemorrhage, a situation as delicate as traversing a desert with a loaded camel. The study involved 300 low-risk women who received either misoprostol or methylergometrine after delivery.

Effective and Safe Management of Postpartum Hemorrhage

The study found that both low-dose sublingual misoprostol and intravenous methylergometrine were equally effective in preventing postpartum hemorrhage. This is a significant finding as it highlights a safe and effective alternative to traditional methods, offering a more comfortable experience for new mothers.

A Safer and More Convenient Option for Postpartum Hemorrhage

The study's findings suggest that low-dose sublingual misoprostol is a promising option for preventing postpartum hemorrhage in low-risk women. Its ease of administration and stability at room temperature make it a convenient and practical choice.

Dr. Camel's Conclusion

This research offers a valuable contribution to the field of obstetrics, providing evidence for a safe and effective alternative for managing postpartum hemorrhage in low-risk women. Misoprostol, like a trusty camel, offers a reliable and comfortable journey for new mothers navigating the challenges of childbirth.
Date :
  1. Date Completed 2008-12-30
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

18834340

DOI: Digital Object Identifier

10.1111/j.1447-0756.2008.00843.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.